Preclinical models for neuroblastoma: establishing a baseline for treatment.

Preclinical models of pediatric cancers are essential for testing new chemotherapeutic combinations for clinical trials. The most widely used genetic model for preclinical testing of neuroblastoma is the TH-MYCN mouse. This neuroblastoma-prone mouse recapitulates many of the features of human neurob...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Tal Teitz, Jennifer J Stanke, Sara Federico, Cori L Bradley, Rachel Brennan, Jiakun Zhang, Melissa D Johnson, Jan Sedlacik, Madoka Inoue, Ziwei M Zhang, Sharon Frase, Jerold E Rehg, Claudia M Hillenbrand, David Finkelstein, Christopher Calabrese, Michael A Dyer, Jill M Lahti
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Public Library of Science (PLoS) 2011-04-01
Rangatū:	PLoS ONE
Urunga tuihono:	http://europepmc.org/articles/PMC3084749?pdf=render
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Preclinical models for neuroblastoma: establishing a baseline for treatment.

Ngā tūemi rite